Article: Stock Watch: (NASDAQ: BBBY) Bed Bath & Beyond Inc., (NYSE: TOL) Toll Brothers, Inc., (NASDAQ: MDCO) The Medicines Company added to W.W. Rolling Stocks.

Article: The Medicines Company Completes $36 Million Private ...
PR Newswire;  August 31, 1998 ;     700+ words ... ... PRNewswire/ -- The Medicines Company and Morgan Stanley ... completion of The Medicines Company's $36 million ... will be used by The Medicines Company to support the development ...

Article: The Medicines Company Strengthens Senior Management ...
Business Wire;  September 25, 2001 ;     700+ words ... ... HealthWire)--Sept. 25, 2001 The Medicines Company (NASDAQ: MDCO) announced today ... 1996 and will continue to lead The Medicines Company on a full-time basis. Reporting ... Kessler, an outside Director of The Medicines Company who was formerly Chief Operating ...

Article: The Medicines Company Acquires Cangrelor, ...
Business Wire;  December 18, 2003 ;     700+ words ... ... Department and Surgical Indications The Medicines Company (Nasdaq: MDCO) announced today ... agreement with AstraZeneca, The Medicines Company has acquired rights to develop ... Korea, Taiwan and Thailand. The Medicines Company will make an upfront payment, will ...

Article: The Medicines Company Strengthens New Jersey ...
Business Wire;  June 4, 2003 ;     700+ words ... ... BUSINESS WIRE)--June 4, 2003 The Medicines Company (Nasdaq: MDCO) today announced ... Campus Drive in Parsippany, NJ. The Medicines Company relocated to Parsippany, NJ in the ... accommodate its expanding needs. The Medicines Company also has offices in Cambridge, MA ...

Article: The Medicines Company Acquires Novel Treatment for ...
PR Newswire;  August 13, 1998 ;     700+ words ... ... Aug. 13 /PRNewswire/ -- The Medicines Company and Immunotech S.A. announced today that The Medicines Company has acquired from Immunotech ... as the second product in The Medicines Company's portfolio of drug candidates ...

Article: The Medicines Company's ANGIOMAX(TM) Brand of ...
PR Newswire;  October 25, 1999 ;     700+ words ... ... Oct. 25 /PRNewswire/ -- The Medicines Company announced today that bivalirudin ... Concurrent with the approval, The Medicines Company announced that the bivalirudin product ... clot formation and extension. The Medicines Company is working with leaders in the international ...

Article: The Medicines Company Reacquires Angiox(R) ...
Business Wire;  July 2, 2007 ;     700+ words ... ... Guidance PARSIPPANY, N.J. -- The Medicines Company (NASDAQ: MDCO) announced today ... approved in 26 European markets. The Medicines Company currently sells Angiomax([R ... annually. This transaction gives The Medicines Company a direct presence in European markets ...